Zimmer Biomet
(NYSE) ZBH
Zimmer Biomet Financials at a Glance
Market Cap
$16.00B
Revenue (TTM)
$8.41B
Net Income (TTM)
$761.30M
EPS (TTM)
$3.85
P/E Ratio
21.47
Dividend
$0.96
Beta (Volatility)
0.64 (Low)
Dividend
$0.96
Beta (Volatility)
0.64 (Low)
Price
$83.00
Volume
1,606,914
Open
$83.08
Price
$83.00
Volume
1,606,914
Open
$83.08
Previous Close
$83.01
Daily Range
$82.14 - $83.68
52-Week Range
$79.83 - $108.29
Dividend
$0.96
Beta (Volatility)
0.64 (Low)
Price
$83.00
Volume
1,606,914
Open
$83.08
Previous Close
$83.01
Daily Range
$82.14 - $83.68
52-Week Range
$79.83 - $108.29
ZBH News
ZBH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zimmer Biomet
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
17,000
CEO
Ivan Tornos, Jr., MBA
Website
www.zimmerbiomet.comHeadquarters
Warsaw, IN 46580, US
ZBH Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
16%
Net Income Margin
9%
Return on Equity
6%
Return on Capital
6%
Return on Assets
3%
Earnings Yield
4.66%
Dividend Yield
1.16%
Payout Ratio
24.88%
Stock Overview
Market Cap
$16.00B
Shares Outstanding
193.57M
Volume
1.61M
Avg. Volume
2.37M
Financials (TTM)
Gross Profit
$5.07B
Operating Income
$1.36B
EBITDA
$2.22B
Operating Cash Flow
$1.70B
Capital Expenditure
$224.50M
Free Cash Flow
$1.47B
Cash & ST Invst.
$591.90M
Total Debt
$7.52B
Zimmer Biomet Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.09B
+9.3%
Gross Profit
$1.51B
+11.1%
Gross Margin
72.39%
N/A
Market Cap
$16.00B
N/A
Market Cap/Employee
$941.31K
N/A
Employees
17,000
N/A
Net Income
$238.10M
+30.8%
EBITDA
$538.30M
-2.1%
Quarterly Fundamentals
Net Cash
$7.05B
-21.7%
Accounts Receivable
$1.73B
+12.7%
Inventory
$2.25B
+0.1%
Long Term Debt
$6.30B
-4.3%
Short Term Debt
$1.18B
+96.0%
Return on Assets
3.35%
N/A
Return on Invested Capital
6.24%
N/A
Free Cash Flow
$322.90M
-3.8%
Operating Cash Flow
$359.20M
-6.2%